Ant Group IPO: Final Say. Strategics, Index Impact
Ant Group will raise USD35bn via an IPO in HK and Shanghai. We have covered various aspects of the deal in our earlier notes. In this note, I'll...
443 Views
Ant Group IPO: Valuation Insights
Ant has launched its concurrent Hong Kong and STAR Market IPO to raise $34.4 billion. Overall, we think that the IPO price is reasonable for a...
377 Views
Ant Group Pre-IPO: Updated Valuation. It’s Going Higher.
Ant Group plans to raise up to US$35bn via in its Hong Kong Exchange and Shanghai STAR board listing. We have covered various aspects of the deal...
462 Views
ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
340 Views
Lufax IPO: Valuation Insights
Our valuation analysis suggests that the IPO price range is unattractive and we would be inclined to give the IPO a pass.
587 Views